NU.H — NeutriSci International Income Statement
0.000.00%
Consumer DefensivesMicro Cap
Annual income statement for NeutriSci International, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.083 | 0.097 | 0.075 | 0.081 | 0.458 |
Cost of Revenue | |||||
Gross Profit | 0.004 | 0.003 | -0.006 | -0.021 | -0.043 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2.47 | 1.71 | 2.03 | 1.65 | 1.23 |
Operating Profit | -2.38 | -1.61 | -1.95 | -1.57 | -0.771 |
Net Income Before Taxes | -2.38 | -1.61 | -1.95 | -1.57 | -0.771 |
Net Income After Taxes | -2.38 | -1.61 | -1.95 | -1.57 | -0.771 |
Net Income Before Extraordinary Items | |||||
Net Income | -2.38 | -1.61 | -1.95 | -1.57 | -0.771 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -2.38 | -1.61 | -1.95 | -1.57 | -0.771 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.023 | -0.014 | -0.014 | -0.009 | -0.004 |